Overview

Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have untreated acute lymphoblastic leukemia.
Phase:
Phase 2
Details
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Collaborator:
National Cancer Institute (NCI)
Treatments:
6-Mercaptopurine
Allopurinol
Asparaginase
Cyclophosphamide
Cytarabine
Daunorubicin
Leucovorin
Levoleucovorin
Mercaptopurine
Methotrexate
Prednisone
Vincristine